The Human Genome in Healthcare
23 - 24 November 2017
The Royal Society, London
| This meeting is a joint event between the Genetics Society and the British Society for Genetic Medicine.
Recent technological advances provide the ability to directly access variation within an individual's genome providing vast potential for personalising and improving heathcare. The ‘Human Genome in Healthcare’ meeting aims explore the science that underpins current and potential future applications of the human genome to inform diagnostics, prognostics and personalisation of therapies.
We have an outstanding line up of speakers from around the world who will provide insight into the approaches through which an individual’s genome can be harnessed to improve healthcare.
Sessions will focus on advances in approaches to interpret an individual's genome in the context of rare disease, common complex disease and cancer alongside approaches aiming to provide more effective personalised therapies. The meeting will explore how the impact of variation within an individuals genome is leveraged from a population scale genotypic and phenotypic standpoint and how individuals are increasingly taking control of their own genomic information to inform health and lifestyle decisions.
Meeting organisers:
Michael Simpson (King’s College London and Genomics plc)
Jim Huggett (LGC & University of Surrey)
Emma Woodward (British Society for Genetic Medicine)
Speakers:
Andrew Wood, University of Edinburgh, UK (Balfour prize lecture)
Clare Turnbull, Genomics England, UK
Richard Treambath, King's College London, UK
Richard Scott, Genomics England, UK
Anna Middleton, Welcome Genome Campus, UK
Madan Babu, MRC, Cambridge, UK
Kaitlin Samocha, Harvard Medical School/Broad Institute, USA
Don Conrad, Washington University School of Medicine, USA
Frank Dudbridge, University of Leicester, UK
Joe Marsh, University of Edinburgh, UK
Denis Lo, Chinese University of Hong Kong, Hong Kong
Serena Nik-Zainal, Sanger Institute, UK
Magnus Ingelman-Sundberg, Karolinska Institute, Sweden
Jakub Tolar, University of Minnesota, USA
Joe Pickrell, New York Genome Centre, USA |
The Royal Society, London
Abstract Submission
Deadline: 25 September 2017
General Information
This meeting is a joint event between the Genetics Society and the British Society for Genetic Medicine.
Recent technological advances provide the ability to directly access variation within an individual’s genome providing vast potential for personalising and improving heathcare. The ‘Human Genome in Healthcare’ meeting aims explore the science that underpins current and potential future applications of the human genome to inform diagnostics, prognostics and personalisation of therapies.
We have an outstanding line up of speakers from around the world who will provide insight into the approaches through which an individual’s genome can be harnessed to improve healthcare.
Sessions will focus on advances in approaches to interpret an individual’s genome in the context of rare disease, common complex disease and cancer alongside approaches aiming to provide more effective personalised therapies. The meeting will explore how the impact of variation within an individuals genome is leveraged from a population scale genotypic and phenotypic standpoint and how individuals are increasingly taking control of their own genomic information to inform health and lifestyle decisions.
Deadline for submissions: 25 September 2017
Meeting organisers:
- Michael Simpson (Genetics Society)
- Jim Huggett (Genetics Society)
- Emma Woodward (British Society for Genetic Medicine)
Speakers:
- Kaitlin Samocha, Harvard Medical School/Broad Institute, USA
- Don Conrad, Washington University School of Medicine, USA
- Joe Marsh, University of Edinburgh, UK
- Denis Lo, Chinese University of Hong Kong, Hong Kong
- Serena Nik-Zainal, Sanger Institute, UK
- Magnus Ingelman-Sundberg, Karolinska Institute, Sweden
- Jakub Tola, University of Minnesota, USA
- Joe Pickrell, New York Genome Centre, USA
